Steve Lundy is CEO & President at AspenBio Pharma, Inc. (APPY). They have made 1 open-market trade across 1 company since 2012, most recently 2012-06-29.
CIK 0001408113
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APPY | 4,000 | $16K |
Shares reported on the most recent Form 4, priced at the 2012-07-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APPY | BUY | 2012-06-29 | 2012-07-02 | $1.93 | $8K | -23.3% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.